DUBLIN--(BUSINESS WIRE)--The "Cardiac Monitoring & Cardiac Rhythm Management Devices Market by Product (ECG, Cardiac Output Monitoring, ILR), CRM (ICDs, External Defibrillator, Pacemaker (Dual Chamber Pacemaker), End User (Home and Ambulatory, Hospital) - Global Forecast to 2022" report has been added to ResearchAndMarkets.com's offering.
The cardiac monitoring and cardiac rhythm management devices market is expected to reach USD 25.12 million by 2022 from USD 20.67 million in 2017, at a CAGR of 4.0% during the forecast period.
The scope of the report includes cardiac monitoring (CM) and cardiac rhythm management (CRM) used for the continuous monitoring, detection, and treatment of heart activities and abnormal heart rhythm (electric heart patterns).
Increasing incidence of cardiovascular diseases and technological advancements in devices are the factors expected to propel the growth of the market. However, price sensitivity and limited reimbursements for remote cardiac monitoring devices are expected to restrain the growth of the CM & CRM devices market.
Major key players in the cardiac monitoring and cardiac rhythm management devices market include Medtronic (Ireland), Abbott (US), Boston Scientific (US), BIOTRONIK (Germany), GE Healthcare (US), and Philips Healthcare (Netherlands).
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
6 CM and CRM Devices Market, By Product
7 Cardiac Monitoring Devices Market, By Product
8 Cardiac Monitoring Market: By Product
9 Cardiac Monitoring and Cardiac Rhythm Management Devices Market, By End User
10 Cardiac Monitoring and Cardiac Rhythm Management Market, By Region
11 Cardiac Monitoring Market: Competitive Landscape
12 Company Profiles
- Applied Cardiac System
- Boston Scientific
- Cardiac Science (A Portfolio Company of the Aurora Capital Group)
- GE Healthcare
- Hill-Rom Holdings
- Philips Healthcare
For more information about this report visit https://www.researchandmarkets.com/research/hfpmf3/cardiac?w=4